Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
Search
Generic filters

Latest

Loading...
Tom Kellner

PBD Biotech expands its North American operations
January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
Tom Kellner

PBD Biotech expands its North American operations
January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...
Tomas Richardson

Disruptive phage technology attracts top scientist to PBD Biotech
January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis” says Dr Tomas Richardson.
Tomas Richardson

Disruptive phage technology attracts top scientist to PBD Biotech
January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis”...

Innovation is a key differentiator, PBD Biotech CEO to say at Invest Midlands
January 17, 2022
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local economy. The recent pandemic has shown the huge value of diagnostics and tuberculosis (TB), for which there are currently few...

Innovation is a key differentiator, PBD Biotech CEO to say at Invest Midlands
January 17, 2022
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local...
Jane Theaker, CEO, PBD Biotech (c) Chelsea Shoesmith Photography - square

Jane Theaker appointed as new CEO as PBD Biotech gears up for next phase of development
December 10, 2021
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is appointing Jane Theaker, of precision medicine company Kinomica, as the new CEO and bringing Commercial Director, Jonnie Yewdall, into a...
Jane Theaker, CEO, PBD Biotech (c) Chelsea Shoesmith Photography - square

Jane Theaker appointed as new CEO as PBD Biotech gears up for next phase of development
December 10, 2021
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is...
Arden Farms deer

Arden Farms first to test deer for Johne’s Disease using Actiphage
October 25, 2021
Arden Farms are the first to use the Actiphage® blood test to test their herd of Red Deer for Johne’s Disease. This wasting condition is difficult to detect as it can lay dormant in the animal for many years until...
Arden Farms deer

Arden Farms first to test deer for Johne’s Disease using Actiphage
October 25, 2021
Arden Farms are the first to use the Actiphage® blood test to test their herd of Red Deer for Johne’s...

Which is the best test for bovine TB?
October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective tools to help prevent and manage the disease

Which is the best test for bovine TB?
October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective...
red_deer_fawn

Actiphage detects Johne’s Disease – the hidden assassin
September 7, 2021
Farmed deer are susceptible to Johne’s Disease, a chronic wasting condition that results in reduced meat yields, lower fertility and premature death. The condition is difficult to detect, but now a proof of concept study has shown that a new...
red_deer_fawn

Actiphage detects Johne’s Disease – the hidden assassin
September 7, 2021
Farmed deer are susceptible to Johne’s Disease, a chronic wasting condition that results in reduced meat yields, lower fertility and...
Jonnie Yewdall

Former dairy farmer joins PBD Biotech’s fight against bovine TB
May 26, 2021
Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to take its Actiphage® blood test for bovine TB (bTB) and Johne’s Disease through the validation required for international industry acceptance.
Jonnie Yewdall

Former dairy farmer joins PBD Biotech’s fight against bovine TB
May 26, 2021
Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to...
1 2 3 … 8

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house